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Abstract
Background: In 2010, EULAR/PRINTO/PRES proposed new classification criteria for paediatric IgA vasculitis (IgAV)
that have a higher diagnostic sensitivity than the 1990 ACR criteria. These criteria have so far not been evaluated in
adults, in whom IgAV is considered as a rare disease. Our main objective was to compare the diagnostic performance
of EULAR/PRINTO/PRES and ACR classification criteria in adult IgAV.
Methods: Adult IgAV cases fulfilling the 2012 revised International Chapel Hill Consensus Conference Nomenclature of
Vasculitides (ICHCCNV) definition of IgAV at a secondary/tertiary rheumatology referral centre were critically reviewed in
a partially retrospective and partially prospective manner. First, we compared the diagnostic sensitivity of ACR
and EULAR/PRINTO/PRES criteria in this group of patients. Second, the diagnostic specificity of ACR and EULAR/
PRINTO/PRES was determined by applying these criteria to a control group of patients with other systemic
vasculitides.
Results: Between 1 January 2010 and 31 December 2014 350 new cases of systemic vasculitis were identified.
IgAV was diagnosed in 129, and other systemic vasculitides in 221 (123 had large, six medium and 92 small vessel
vasculitis) cases according to ICHCCNV. The diagnostic sensitivity and specificity of the IgAV EULAR/PRINTO/PRES
criteria were 99.2 % (95 % CI 95.4–99.9 %) and 86.0 % (95 % CI 80.7–90.3 %), and of the ACR criteria 86.8 % (95 %
CI 79.7–92.1 %) and 81.0 % (95 % CI 75.2–85.9 %), respectively with an inter-criteria agreement of 77.5 % (95 % CI:
70.8–84.1 %).
Conclusions: In the adult population the EULAR/PRINTO/PRES IgAV classification criteria had a higher sensitivity
and specificity than the ACR criteria.
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Background
Immunoglobulin A-associated vasculitis (IgAV; formerly
known as Henoch-Schönlein purpura) is a leucocytoclas-
tic, immune complex-mediated, small vessel vasculitis
characterized clinically by palpable purpura, joint, gastro-
intestinal, or renal involvement and histologically by the
predominance of IgA deposits in the vascular wall. IgAV
is regarded as a disease of childhood. However, we have
recently shown that IgAV, contrary to common belief, is
by no means rare in adults. Our findings suggest a 3–6
times higher incidence rate of adult IgAV than previously
reported [1].
The diagnosis of IgAV is based on the signs, symp-
toms, and histopathological findings. European League
Against Rheumatism/Paediatric Rheumatology Inter-
national Trials Organisation/Paediatric Rheumatology
European Society (EULAR/PRINTO/PRES) recently pub-
lished new classification criteria for childhood vasculitides,
including IgAV. In children, IgAV criteria performed bet-
ter than the older American College of Rheumatology
(ACR) classification criteria (Table 1) [2, 3]. A recent
Spanish study reported a 52.3 % concordance between the
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EULAR/PRINTO/PRES and the ACR IgAV criteria in a
mixed paediatric and adult historic cohort [4].
Thus far the performance of the EULAR/PRINTO/
PRES criteria not been evaluated in an exclusively adult
population. Our main objective was to compare the
diagnostic sensitivity and specificity of the EULAR/




This partially retrospective (from 1 January 2010 to 31
December 2012), partially prospective (from 1 January
2013 to 31 December 2014) observational study was per-
formed at the Department of Rheumatology, University
Medical Centre Ljubljana, Slovenia. The University Med-
ical Centre Ljubljana is an integrated teaching hospital,
serving approximately 1,060,000 adult residents at the
tertiary level, and is the only secondary level referral
hospital in the Ljubljana region, serving approximately
530,000 adult residents.
Patients and diagnostic criteria
Adults, i.e. persons aged ≥18 years, with systemic vascu-
litis, diagnosed for the first time during the observation
period, were included. Cases fulfilling the 2012 revised
International Chapel Hill Consensus Conference No-
menclature of Vasculitides (ICHCCNV) definition of
IgAV represented the studied cohort. ICHCCNV and
1990 ACR classification criteria for systemic vasculitides
were used to classify patients with giant cell arterits
(GCA), Takayasu arteritis, polyarteritis nodosa (PAN),
ANCA-associated vasculitides (AAV), and Cogan syn-
drome [2, 5–9]. The International Study Group for Beh-
çet’s Disease criteria were used for Behçet syndrome,
[10] preliminary classification criteria for the cryoglobu-
linaemic vasculitis, [11] and criteria proposed by Cala-
brese for diagnosing primary angiitis of the central
nervous system [12].
For the retrospective part of the study, cases with vas-
culitis were ascertained by searching the electronic med-
ical records for the 10th revision of the International
Statistical Classification of Diseases code for the particu-
lar vasculitis.
Patients with systemic vasculitis other than IgAV served
as controls. We used both the 1990 ACR and the 2010
EULAR/PRINTO/PRES classification criteria (Table 1) in
our cohort of IgAV patients and controls.
Diagnostic work-up
After a thorough clinical evaluation, patients underwent
an extensive laboratory work-up in accordance with the
established local vasculitis management protocol. Markers
of systemic inflammation [erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP)], a complete blood count
with differential, basic biochemistry panels including elec-
trolytes, creatinine, urea, liver function tests, muscle en-
zymes, serum electrophoresis, urine analysis were done in
all patients. Immunoserological screening routinely per-
formed in case of vasculitis included Hep-2 test, anti-
bodies against extractable nuclear antigens (Sm, U1RNP,
Ro, La, Scl-70, Jo-1, PCNA, PM/Scl, SL, Ku), rheumatoid
factor; anti-neutrophil cytoplasmic antibodies (ANCA)
against myeloperoxidase (anti-MPO) and proteinase 3
(anti-PR3); cryoglobulins, C3c and C4. When appropriate
(e.g. in case of thrombotic complications), antiphospholi-
pid antibodies (anticardiolipin antibodies, anti-beta-2-
glycoprotein I antibodies and lupus anticoagulants) were
also determined.
All tissue biopsies, except those of the temporal arter-
ies, were evaluated using both bright field microscopy to
confirm leucocytoclastic vasculitis or glomerulonephritis
and direct immunofluorescence to demonstrate IgA or
other immunoglobulin (IgM, IgG), fibrin/fibrinogen and
complement deposits.
The use of imaging, endoscopy and sub-speciality con-
sultations was guided by the clinical picture.
Statistical analysis
Diagnostic sensitivity, specificity and the inter-criteria
agreement Cohen’s kappa coefficient of EULAR/PRINTO/
PRES and ACR IgAV criteria were determined. Compari-
sons between classification criteria were done using the
Table 1 Classification criteria for IgA vasculitis
ACR classification criteria (1990) [2] EULAR/PRINTO/PRES classification criteria (2010) [3]
Two of the following criteria:
• age≤ 20 years
• palpable purpura
• acute abdominal pain
• biopsy showing granulocytes in the walls of the small arterioles
or venules
• Purpura or petechiae
AND
• One of the following four criteria
◦ abdominal pain
◦ arthritis or arthralgia
◦ renal involvement
◦ leucocytoclastic vasculitis with predominant IgA deposits or
proliferative glomerulonephritis with predominant IgA deposits
sensitivity 87.1 %; specificity 87.7 % sensitivity 100 %; specificity 87 %
IgA immunoglobulin A-associated, ACR American College of Rheumatology, EULAR/PRINTO/PRES European League Against Rheumatism/Paediatric Rheumatology
International Trials Organisation/Paediatric Rheumatology European Society
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mid-P variant of McNemar’s test. InteractiVenn online
software was used to draw the Venn diagrams [13].
Patient consent and ethics committee approval
Patient consent was not needed since the collected
data stems from routine clinical practice. The study
was approved by the Slovenian National medical eth-
ics committee.
Results
During the 60-month observation period, between 1
January 2010 and 31 December 2014, 350 new patients
with vasculitis were identified, including 129 IgAV cases
(67 retrospectively and 62 prospectively) (Table 2).
Fifty-eight percent of the IgAV patients were male.
The median age at the time of presentation was
64.2 years [range 18–92, interquartile range (IQR) 40.4–
77.3]. Four patients were younger than 21 years. Palpable
purpura was present in all patients. Fifty-eight (45 %) pa-
tients had joint involvement. Gastrointestinal (GI) in-
volvement was present in 48 (37.2 %) patients and
kidneys were affected in 65 (50.4 %) patients. All IgAV
patients underwent a skin biopsy. Leucocytoclastic vas-
culitis was present in 124/129 (96.1 %) patients. In five
patients only perivascular infiltration was seen. Granulo-
cytes in vessel wall were found in 106 (82.2 %) cases.
IgA-dominant immune vascular deposits were demon-
strated in the tissue biopsy specimens from all IgAV
patients.
Our control group consisted of 221 cases with vascu-
litis other than IgAV diagnosed during the same time
period. Large vessel vasculitis was diagnosed in 123
cases, medium vessel vasculitis in six and small vessel
vasculitis in 92 cases (Table 2).
Comparison of classification criteria
In the IgAV cohort, 112/129 (86.8 %) patients fulfilled
ACR, and 128 (99.2 %) patients EULAR/PRINTO/PRES
IgAV criteria. The criteria fulfilled in the cases classified
by either criteria are depicted in the Venn diagrams
(Fig. 1).
In the control group, 31/221 (14.0 %) patients could
also be classified as IgAV using EULAR/PRINTO/PRES,
and 42/221 (19.0 %) by ACR IgAV criteria. Twenty-five
controls (11.3 %) fulfilled both IgAV classification cri-
teria. Six (2.7 %) controls fulfilled exclusively EULAR/
PRINTO/PRES and 17 (7.7 %) controls exclusively ACR
IgAV criteria. Twenty-nine out of 31 (93.5 %) controls
that fulfilled the EULAR/PRINTO/PRES IgAV classifica-
tion criteria, did so by clinical items (i.e. purpura plus
joint and/or GI tract and/or kidney involvement). Two
cases, classified as cryoglobulinaemic vasculitis based on
a history of recurrent episodes of purpura, nephritis and
in one case a peripheral neuropathy, the presence of
cryoglobulins, low C4, and disease evolution on follow-
up, additionally fulfilled the histological item of the
EULAR/PRINTO/PRES criteria – i.e. the demonstration
of predominant IgA immunoglobulin deposits on the
skin biopsy.
The sensitivity and specificity of IgA-dominant vascu-
lar deposits in the case of small vessel vasculitis for IgAV
were 100 % (95 % CI: 97–100 %) and 97.8 % (95 % CI:
Table 2 Vasculitides diagnosed between January 2010 and December 2014
Classified as IgAV by
All (N) EULAR/PRINTO/PRES criteria (N) ACR criteria (N)
IgA vasculitis 129 128 112
Controls 221 31 42
Giant cell arteritis 121 0 0
ANCA-associated vasculitis 38 13 11
Cryoglobulinaemic vasculitis 18 10 14
Secondary vasculitis 11 5 8
Single organ vasculitis 8 0 8
Behçet syndrome 7 0 0
Polyarteritis nodosa 6 0 0
Takayasu arteritis 2 0 0
Cogan syndrome 2 0 0
Anti-GBM disease 1 0 0
Primary angiitis of the central nervous system 1 0 0
Anti-C1q vasculitis 1 0 0
Unclassified vasculitis 5 3 1
IgAV immunoglobulin A-associated vasculitis, EULAR/PRINTO/PRES European League Against Rheumatism/Paediatric Rheumatology International Trials Organisation/
Paediatric Rheumatology European Society, ACR American College of Rheumatology, ANCA anti-neutrophil cytoplasmic antibodies, GBM glomerular basement membrane
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92.3–99.7 %), respectively with a positive predictive
value of 98.5 % (95 % CI: 94.6–99.8 %).
The controls that fulfilled the ACR IgAV criteria did
so on the basis of clinical items in 4/42 cases only. The
remaining 38 cases met the ACR criteria by the combin-
ation of clinical and histological items.
The diagnostic sensitivity and specificity of the
EULAR/PRINTO/PRES vs the ACR IgAV criteria were
99.2 % (95 % CI: 95.4–99.9 %) vs 86.8 % (95 % CI: 79.7–
92.1 %) (p = 0.02) and 86.0 % (95 % CI: 80.7–90.3 %) vs
81.0 % (95 % CI: 75.2–85.9 %) (p < 0.01), respectively.
The positive and negative likelihood ratios of the
EULAR/PRINTO/PRES vs the ACR IgAV criteria were
7.07 (95 % CI: 5.10–9.81) vs 4.57 (95 % CI: 3.45–6.05)
and 0.01 (95 % CI: 0.00–0.06) vs 0.16 (95 % CI: 0.10–
0.25), respectively. The inter-criteria agreement Cohen’s
kappa coefficient was 77.5 % (95 % CI 70.8–84.1 %).
Discussion
In the absence of diagnostic criteria for the systemic vas-
culitides, clinicians often rely on the existing classifica-
tion criteria when faced with a patient presenting with
kaleidoscopic symptoms and signs suggestive of systemic
vasculitis to make the final diagnosis. Early and correct
diagnosis is of paramount importance for favourable
outcomes. A glimpse of the recent new insights into
these complex diseases is reflected in the ICHCCNV,
which has not yet been followed by an update of the
classification criteria [6].
In the case of IgA vasculitis we usually rely on the
1990 ACR IgAV classification criteria. They were based
on the data analysis from 807 patients with systemic vas-
culitides, 85 of them were classified as having IgAV [2]. In
2010, the Pediatric Rheumatology European Society
(PRES) endorsed by the EULAR published a new set of
classification criteria for paediatric vasculitides, including
the IgAV. The EULAR/PRINTO/PRES IgAV classification
criteria are based on data analysis from 827 children with
IgAV. In children, the newer EULAR/PRINTO/PRES cri-
teria have a higher diagnostic sensitivity than the older
ACR criteria without any loss of diagnostic specificity
(Table 1) [3].
This is the first report evaluating the performance of
the new EULAR/PRINTO/PRES criteria in an exclu-
sively adult cohort. Our data suggests that, like in the
paediatric population, the EULAR/PRINTO/PRES are
more sensitive than the older ACR IgAV criteria in the
adult population. The two main reasons for the in-
creased sensitivity of the EULAR/PRINTO/PRES are the
addition of joint and kidney involvement, and the modi-
fication of the histopathological criterion by the addition
of the IgA vessel wall deposition. Considering only the
clinical items of both criteria sets, diagnosis of IgAV
could be made in about 80 % and 40 % of cases if the
EULAR/PRINTO/PRES and ACR criteria were used, re-
spectively. While all our patients had purpura with lower
limb predominance, the clinical items of the ACR cri-
teria were only fulfilled by four patients younger than
21 years, and 48 of those with GI involvement. Although
the sensitivity of the ACR criteria improved when we
considered the histopathology, it still lagged behind that
of the EULAR/PRINTO/PRES criteria. In our cohort the
ACR histological criterion, requiring granulocyte infiltra-
tion of the vessel wall, was not met in 23 (17.8 %) of
IgAV patients, while leucocytoclastic vasculitis with IgA
deposits was found in 124 (96.1 %) IgAV patients and
lone IgA vascular deposits in five cases. The reason for
the inability to prove vasculitis in some cases might rest
in the fact that fresh skin lesions were not always obtain-
able. In these cases, perivascular inflammatory infiltrates
and the demonstration of IgA deposits in the vessel
walls implied IgAV. Considering all four ACR criteria
Fig. 1 Venn diagram of the classification criteria items fulfilled during the acute phase of the disease. a American College of Rheumatology
criteria (1990). b European League Against Rheumatism/Paediatric Rheumatology International Trials Organisation/Paediatric Rheumatology
European Society criteria (2010)
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items, 17 (13.2 %) patients from our IgAV cohort did not
meet the classification criteria, compared to a single one
(0.8 %) when using the EULAR/PRINTO/PRES criteria
(Fig. 1). The EULAR/PRINTO/PRES criteria also have a
significantly higher diagnostic specificity than the ACR
IgAV criteria (86.0 % vs 81.0 %, p = 0.023). The validity
of our results is supported by the recent Spanish study,
which suggested the applicability of EULAR/PRINTO/
PRES IgAV criteria and showed that these criteria were
fulfilled more often than ACR or Michel criteria in the
adult subset of the mixed paediatric and adult cohort of
patients with primary cutaneous vasculitis. However,
they only found a 52.3 % concordance between the
EULAR/PRINTO/PRES and ACR IgAV criteria [4]. The
majority (93.5 %) of controls were misclassified as IgAV
when using the EULAR/PRINTO/PRES criteria based
on the clinical items. Only two controls were misclassi-
fied as IgAV by the demonstration of IgA-dominant im-
munoglobulin deposits on the skin biopsy. In contrast,
more than 95 % of the controls misclassified as IgAV
when using ACR criteria also fulfilled the histological
criterion. The demonstration of IgA deposits, required
by the EULAR/PRINTO/PRES criteria, significantly nar-
rows down the differential diagnosis of the leucocytoclas-
tic small vessel vasculitis and enhances the diagnostic
specificity of these criteria. Our observation is in disparity
with Larson who reported an 86 % diagnostic sensitivity
and an 84 % specificity of IgA deposits [14].
The most obvious limitations of our study are that
it was conducted in a single secondary/tertiary centre
making it subject to a channelling bias, its partly
retrospective nature, and the rather small sample size.
Yet we feel that the results of the first study compar-
ing the EULAR/PRINTO/PRES and ACR IgAV criteria
are compelling due to the thorough systematic clinical
and laboratory work-up of patients suspected of hav-
ing systemic vasculitis and the inclusion of histologi-
cally proven IgAV cases.
Conclusions
The use of the EULAR/PRINTO/PRES criteria in the
adult population seems feasible, given that they are more
sensitive and specific than the 1990 ACR IgAV criteria.
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